CFHR3 and hemolytic-uremic syndrome: DEAP-HUS patients who developed autoantibodies to Factor H present frequently with a homozygous deletion of the CFHR1-CFHR3 segment or alternatively but rarely by a compound heterozygous CFHR1-CFHR3, together with CFHR3-CFHR4 deletions (48).